The method rose when buyers depended on sellers for product information. It has declined as research has moved online, but still fits complex B2B deals where the product is configurable and the buyer cannot self-diagnose the full solution.
Solution selling is a B2B sales methodology where the rep first diagnoses a buyer's business problem through structured questioning, then prescribes a tailored combination of products and services that solves it. Mike Bosworth created the approach at Xerox in the 1970s, Keith Eades formalized it at Sales Performance International in the 1990s. The flow is pain, vision, commitment: surface a specific pain, co-create a vision of the fix, then earn a buying commitment.
The six things to know about solution selling before applying it, borrowing from it, or deciding it no longer fits the deal in front of you.
A rep practicing solution selling does not open the call with a product pitch. The opening move is a structured diagnostic conversation: what is broken, what is it costing, who feels the pain, what has already been tried. The product only enters the conversation after the problem is named, shared, and quantified.
Mike Bosworth developed the approach at Xerox while selling complex mainframe and copier systems that buyers could not evaluate on features alone. He left Xerox in 1983, founded Solution Selling in 1988, and published the book of the same name in 1994. The methodology was taught through workshops and licensed curriculum for the next two decades.
Keith Eades, a Bosworth collaborator, acquired the methodology and formalized it at Sales Performance International (SPI). His 2003 book The New Solution Selling introduced a structured playbook with pain sheets, reference stories, and a repeatable buying-process map. SPI trained hundreds of thousands of enterprise reps through the 2000s and 2010s.
The three-stage flow is the heart of the method. Pain: surface a specific business problem with a cost attached. Vision: co-create with the buyer a mental picture of how the solved state looks and feels. Commitment: convert the shared vision into a buying commitment by sequencing the proof the buyer needs to say yes.
Solution selling fits deals where the product is not a shelf item: enterprise software, industrial equipment, managed services, custom integrations. It fits buyers who cannot fully diagnose their own problem, and products whose value depends on how they are configured. It does not fit transactional sales where the buyer already knows what they want.
The approach has lost ground since 2010. Research by CEB (now Gartner) found B2B buyers complete about 57 percent of the purchase decision before they talk to a rep. When the buyer has already diagnosed the problem and sized the solution, the sell-side diagnostic conversation feels patronizing rather than helpful, and newer methods like Challenger adapted around that shift.
The method is a sequence, not a script. Each step builds the pattern the next step needs. A rep who skips a step and goes straight to a demo loses the frame that makes the demo land. The six moves below are the ones Bosworth and Eades taught, stripped of jargon.
Before the call, the rep assembles reference stories: short narratives about similar customers in similar roles with similar pain and the measured outcome after the fix. One story per persona and pain pattern. These are the raw material of the diagnostic conversation, used to prompt the buyer to recognize themselves in the pattern.
The rep opens with a reference story and asks whether any of it sounds familiar. If the buyer says yes, the rep leads a structured conversation about who feels the pain, what triggers it, how often, what workarounds exist, what the current fix costs. The output is a named pain with a dollar impact, not a feature request.
Once the pain is named, the rep moves to vision processing: a Socratic dialogue where the rep asks the buyer to describe how the solved state would look. The rep adds capabilities one at a time, letting the buyer own the picture. The buyer leaves the call with a vision they feel they built, not one that was sold to them.
With a vision in place, the rep works with the buyer to size the impact: cost of the pain today, value of the solved state, time to break even. The number is the buyer's number, derived from their own data, not a vendor ROI calculator. The value case has to survive the economic buyer's scrutiny when the rep is not in the room.
Solution selling is explicit that the first contact is rarely the final approver. The rep trades value, insight, and references for access to the economic buyer. The move is sequenced: deliver value to the champion, let the champion sponsor the introduction, confirm the economic buyer in writing before investing in further proof.
Rather than one closing moment, the method sequences a chain of smaller commitments: an exploratory meeting, a technical validation, a reference call, a pilot. Each commitment advances the deal and tests the buyer's intent. If the buyer will not grant the small commitment, the big one will not land, and the rep saves cycle time by qualifying out early.
The two approaches share a product and a buyer. Everything else is different: the opening, the questioning, the demo, the proof, the close, and the way the rep is measured. The contrast below is why solution selling existed in the first place, and why the sales-training industry grew up around teaching it.
A product-selling opener is a slide about the vendor, the product, and the market. A solution-selling opener is a short story about another customer with a similar pain and a measurable outcome. The product opener invites objections. The reference-story opener invites recognition and the first diagnostic question.
Product selling asks what features the buyer wants, then matches features to the product. Solution selling asks what business problem the buyer is solving, who it affects, and what it costs. Features enter the conversation at the end, as the specific pieces of the vision the buyer co-authored, not a checklist.
Product demos tour the full product. Solution-selling demos follow a script keyed to the named pains from the discovery conversation. Each screen answers a pain the buyer already owns, in the order the buyer named them. The rep never shows a feature that was not asked for, because every feature shown without a pain hook is friction, not value.
Product selling proves claims with spec sheets, benchmarks, and technical documents. Solution selling proves claims with reference customers who talk peer-to-peer about the outcome they got. The spec sheet is still in the proposal, but the trust-building move is the reference, because peers persuade buyers that vendors cannot.
A product-selling rep opens with a list price and discounts to close. A solution-selling rep opens with the dollar impact of the pain and anchors the price to a fraction of that impact. The buyer compares the ask to the problem, not to a competitor's list price. The resulting discussion is about value share, not discount depth.
Product-selling orgs measure dials, demos, and quota attainment. Solution-selling orgs measure deal quality: pain documented, economic buyer identified, vision co-authored, value quantified. The leading indicators change what reps do with their day and what the forecast actually represents when it rolls up.
Solution selling was built for a world where sellers controlled product information. That world ended somewhere between 2005 and 2015. The buyer behavior shift is well documented and is the direct cause of the methodology's loss of ground to newer approaches. The six forces below are the ones every sales leader has seen first hand since 2015.
Before the rep gets a meeting, the buyer has Googled the problem, read competitor product pages, watched teardown videos on YouTube, and read peer reviews on G2 or Capterra. The structured diagnostic conversation that opens solution selling now feels like the rep is asking the buyer to repeat work they already did.
Gartner research puts the typical B2B buying committee at six to ten people. The old solution-selling flow assumed deep access to one or two champions. When the economic buyer, legal, security, procurement, and three business owners all sit on the committee, the methodology's one-on-one Socratic style scales poorly.
Peer review platforms let buyers hear from customers without ever asking the vendor. The reference-call move that was once the trust capstone of a solution-selling cycle is still useful, but it is no longer the first time the buyer hears a peer. By the time the rep offers a reference, the buyer has already read fifty.
In 2011 CEB (Matt Dixon and Brent Adamson) published The Challenger Sale, which argued that top reps teach the buyer something new about their business rather than asking the buyer to describe the problem. Challenger explicitly positioned itself as the successor to solution selling, and most enterprise sales orgs adopted at least part of it in the decade that followed.
In SaaS, product-led growth lets buyers trial, configure, and expand without a sales conversation. When the buyer can prove the value in a free workspace in an afternoon, the pain-vision-commitment arc is compressed into a self-serve signup. Sales enters later, around expansion and procurement, with a very different mandate.
The methodology's core disciplines, structured discovery, documented pain, buyer-authored vision, value quantification, sequenced commitments, still show up in every modern sales process worth running. The scripted ritual of a 1990s solution-selling call does not. Leaders borrow the bones and skip the choreography.
The methodology is only as good as the system reinforces it. If the CRM has one text field for notes, the pain discovery turns into unstructured prose that leadership cannot inspect. The configuration below is the minimum structure a solution-selling team needs its CRM to carry, so the methodology survives contact with the pipeline.
Deal records carry explicit fields for the business pain, the person who feels it, the cost today, the current workaround, and the trigger event. The fields are required before a deal advances past qualification. Managers can inspect pain documentation in pipeline reviews without reading a wall of notes.
A solution template is a saved product-and-services bundle keyed to a named pain pattern. When a rep documents a pain of type X, the CRM suggests the solution template that fits. The template seeds the proposal and the implementation plan, so the diagnosis-to-prescription handoff is one click, not a copy-paste exercise.
Reference customer stories live as records tagged by persona, industry, pain pattern, and quantified outcome. Reps search the library before every discovery call and pull the right story to open the conversation. The library is maintained by marketing and customer success, so stories stay accurate and consented.
A value model lives on the deal: cost of pain today, projected outcome, payback period, net impact over three years. The numbers are the buyer's, not the vendor's. The model prints into the proposal and the business case the economic buyer takes to committee. The forecast weight reflects the value case, not just the stage.
Pipeline stages require specific evidence to advance: pain documented, economic buyer identified, vision confirmed in writing, value case buyer-approved, next commitment calendared. The stage definitions enforce the methodology, so the forecast reflects the real state of each deal rather than a rep's instinct about it.
A new rep lands into a playbook that cues the next move at every stage: which questions to ask, which story to tell, which proof to offer, which commitment to request. The playbook is editable by sales ops as the method evolves. Ramping a new rep stops being a two-quarter art project and starts being a repeatable process.
Strkr ships structured pain fields, solution templates, reference libraries, value models, and stage-gated playbooks out of the box, so the methodology lives in the pipeline instead of in a training deck. Pricing is published and the platform tour shows exactly what ships today.
Mike Bosworth developed the approach at Xerox in the 1970s and formalized it when he founded Solution Selling in 1988. He published the first edition of Solution Selling in 1994. Keith Eades acquired the methodology and ran it through Sales Performance International, publishing The New Solution Selling in 2003, which is the version most enterprise sales organizations trained on through the 2000s and 2010s.
Product selling leads with features and matches products to a buyer's stated requirements. Solution selling leads with a diagnostic conversation to surface the buyer's business pain, then prescribes a tailored combination of products and services that resolves it. The product-selling demo tours the full product. The solution-selling demo is scripted around the specific pains the buyer named during discovery.
The core flow is pain, vision, commitment. The expanded sequence usually runs: preparation with reference stories, pain discovery, vision processing where the buyer co-authors the solved state, value justification in the buyer's own numbers, access to the economic buyer, and commitment sequencing through a series of small yeses that end in a buying decision.
The disciplines are still relevant: structured discovery, documented pain, buyer-authored vision, quantified value, sequenced commitments. The scripted 1990s ritual is not. Buyers now complete most of their research online before the first sales call, so the opening diagnostic conversation feels redundant in many deals. Newer methods like Challenger adapted the core ideas to a research-first buyer.
Complex B2B deals where the product is configurable, the buyer cannot fully self-diagnose the solution, and the deal size justifies a long sales cycle. Enterprise software, industrial equipment, managed services, custom integrations, and professional services engagements are typical fits. It is a poor fit for transactional sales, self-serve SaaS, and commoditized products where the buyer already knows what they want.
A rep selling a logistics platform opens a call with a story about another mid-market shipper who was losing one percent of revenue to late deliveries. The buyer recognizes the pattern. The rep walks through where the current pain lives, who feels it, and what it costs per quarter. Together they sketch a solved state with real-time visibility and automated exception handling. The proposal bundles the platform, the integration, and a managed-service tier priced against the pain cost.
The two overlap heavily. Consultative selling is a broader category that describes any sales approach where the rep acts as an advisor rather than a pitchman. Solution selling is one specific consultative methodology with a defined flow (pain, vision, commitment) and a named curriculum. Every solution seller is a consultative seller, but not every consultative seller follows the Bosworth or Eades playbook.
The three-stage arc at the center of solution selling. Pain: the rep leads a structured conversation to surface a specific business problem, name who feels it, and quantify what it costs. Vision: the rep and buyer co-author a mental picture of the solved state, with the buyer owning the picture. Commitment: the rep sequences a chain of small buying commitments that end in a signed deal.
No sales call, no migration consultant, no four-month implementation. Enter your card, get 14 days of the full Pro tier, cancel any time before day 14 with zero charge. Spin up a workspace, import your CSV, and have something useful before lunch.
